TCL Archive As Bristol’s Final Defenses Fall, IVAX Prepares Launch Of Generic Paclitaxel. October 20, 2000
TCL Archive EPO Controversy: ODAC To Review EPO Agents in May; SEC Probes Amgen’s Delay in Study Disclosure. March 2, 2007
TCL Archive Also Von Eschenbach role in industry program raises new concerns of conflict of interest. November 23, 2005
TCL Archive Research vs. Delivery? Advisors Debate NCI Role In Review of Community Program. November 21, 2008
